Home

STEPHEN H RUSCKOWSKI

CIK 1142624 · Chairman, CEO and President · last filed 2026-06-02

STEPHEN H RUSCKOWSKI is a Chairman, CEO and President who has filed 74 SEC Form 4 insider transactions across 6 companies since 2012. The most recent filing, for ORCL, was dated Jun 2, 2026. Across all open-market trades the lifetime net is −$201.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $103.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$103.45M

Companies

6

Total Filings

74

Lifetime Open-Market Net

-$201.72M

Filer Profile

Reported Address
ONE BAXTER PARKWAY
DEERFIELD, IL 60015
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ORCL Director — $158.78 — $0 2 2026-06-02
THC Director 5,233 $265.05 $1.39M $0 4 2025-05-27
BAX Director 16,499 $25.83 $426.2K $0 3 2025-05-08
DGX Chairman, CEO and President 428,201 $237.14 $101.54M -$201.72M 55 2023-03-08
XRX Director 26,928 $3.32 $89.4K $0 6 2018-01-16
Covidien plc (COV) Delisted Director 2,977 — — $0 3 2014-03-21

Recent Filings

74 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-02 ORCL Grant (A) — $0 EDGAR
2025-11-20 ORCL Grant (A) — $0 EDGAR
2025-05-27 THC Mixed +1,551 $0 EDGAR
2025-05-08 BAX Grant (A) +7,183 $0 EDGAR
2024-05-28 THC Grant (A) — $0 EDGAR
2024-05-09 BAX Grant (A) +5,952 $0 EDGAR
2023-08-23 BAX Grant (A) +3,049 $0 EDGAR
2023-06-23 THC Grant (A) +3,682 $0 EDGAR
2023-05-30 THC Grant (A) +2,846 $0 EDGAR
2023-03-08 DGX Mixed +44,027 $6.51M EDGAR
Showing 1–10 of 74
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.